Collaborative Arrangements and Pending Acquisition (Tables)

3 Months Ended

Mar. 31, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Collaborative Arrangement Activity Net Loss Attributable to Noncontrolling Interest

An aggregate summary of net income attributable to noncontrolling interest related to the Company’s VIEs for the three months ended March 31, 2017 and 2016 is as follows:

	Three Months Ended March 31,
	2017			2016
	(in thousands)
Loss attributable to noncontrolling interest before provision for income taxes	$	1,547		$	839
Provision for income taxes	391			3,062
Increase in fair value of contingent payments	(3,730		)	(9,430		)
Net income attributable to noncontrolling interest	$	(1,792	)	$	(5,529	)

Changes In Fair Value Of Contingent Consideration

During the three months ended March 31, 2017 and 2016, the increase in the fair value of the contingent payments related to the Company’s VIEs was as follows:

	Three Months Ended March 31,
	2017		2016
	(in thousands)
Parion	$	2,830	$	9,000
BioAxone	900		430

Schedule Of Collaborative Arrangement Summary Of Items Related To Variable Interest Entities

The following table summarizes items related to the Company’s VIEs included in the Company’s condensed consolidated balance sheets as of the dates set forth in the table:

	March 31, 2017		December 31, 2016
	(in thousands)
Restricted cash and cash equivalents (VIE)	$	44,564	$	47,762
Prepaid expenses and other current assets	5,957		6,812
Intangible assets	284,340		284,340
Goodwill	19,391		19,391
Other assets	687		399
Accounts payable	1,080		415
Taxes payable	1,159		1,330
Other current liabilities	1,998		2,137
Deferred tax liability, net	133,058		131,446
Other liabilities	300		300
Noncontrolling interest	182,785		181,609